What is Volibo 0.3mg (ACARBOSE)?
Alpha-glucosidase inhibitor for type 2 diabetes and longevity/anti-aging protocols. Reduces postprandial blood glucose spikes. Studies show potential lifespan extension in animal models.
How it Works
Competitively inhibits intestinal alpha-glucosidases — delays carbohydrate digestion and glucose absorption, blunting postprandial glucose excursion without stimulating insulin.
Quick Specs
- Form
- Oral tablets — pre-dosed
- Active Ingredient
- ACARBOSE
- Dose per Tablet
- 0.3MG
- Pack Size
- 10×10 (100 tablets)
- Storage
- Room temperature (15–25°C), cool dry place
- Shelf Life
- 2–3 years (properly stored)
Common Side Effects
GI effects (flatulence, diarrhea, abdominal pain and bloating) — nearly universal especially initially, dose-dependent, often improve over time.
Safety Warnings
GI inflammation or intestinal obstruction contraindicated. Hypoglycemia only when combined with insulin or sulfonylureas — treat with glucose (NOT sucrose/table sugar — won’t absorb). Monitor liver enzymes. International shipping: 7–14 days